 BOSTON, March 07, 2022 GLOBE NEWSWIRE -- AVEO Oncology Nasdaq: AVEO, a commercial stage, oncology-focused biopharmaceutical company, today announced that it will report full year 2021 financial results on Monday, March 14, 2022. AVEOs management team will host a conference call and audio webcast at 8:30 a.m. ET on Monday, March 14, 2022, to discuss the financial results and provide a business update. 